The Effect of Pranayama Breathing Exercise on Quality of Life in Lung Cancer Patients

NCT05985824 | Completed

• 1 other identifier: SANKOU-HEM-ZD-01
• Study Type: interventional
• Target: 72
• Locations: 1 country
• Sites: 1

Brief Summary

This research is a randomized controlled experimental study to determine the effect of pranayama breathing exercise applied to patients with lung cancer on quality of life.

Conditions

Lung Cancer

Keywords

Lung cancer; Pranayama; Quality of Life; Nursing

Outcome Measures

Primary Outcomes (1)

• Quality of life of lung cancer patients

  European Organization for Cancer Research and Treatment Quality of Life Scale :measure lung cancer patients before and four weeks aftter. European Organization for Cancer Research and Treatment Quality of Life Scale: scale consists of 3 sub-titles: general well-being, functional area and symptom control. While the maximum score that patients will get from these three sub-headings is 100, the minimum score is 0. The first 28 questions are questions related to the functional area and symptom control subheadings, and low scores on these questions mean high quality of life, and high scores mean low quality of life. The last two questions belong to the sub-heading of general well-being, and a low score on these questions indicates a low quality of life, and a high score indicates a high quality of life.

  four weeks

Study Arms (2)

Applications to the Intervention Group

EXPERIMENTAL

Patients with lung cancer admitted to the outpatient chemotherapy unit will be given pranayama breathing exercises every day for 4 weeks, covering 15-20 minutes. In patient education, the pranayama breathing exercise will be applied face-to-face by the researcher on the first day of chemotherapy treatment, before drug treatment. The application steps will be repeated until the patient learns, both by explaining and showing the patient, and if there are points that the patient cannot do, they will be corrected. When the patients are observed to perform the application fully and the chemotherapy treatments are finished, they will be asked to do the pranayama breathing exercise every day for 4 weeks, and with the same researcher 3 days a week (Monday, Wednesday, Saturday) with a smart phone whatsapp video call, the effectiveness and continuity of the application will be ensured and the patients will be monitored.

Procedure: Pranayama breathing exercise

Applications to the Control Group

NO INTERVENTION

A pre-test will be applied to lung cancer patients in the control group who applied to the day chemotherapy unit. After the application of the personal information form and the quality of life scale, no breathing exercises will be performed. Individuals will continue their daily lives. After 4 weeks, the quality of life scale will be administered again. After the implementation of the quality of life scale, pranayama breathing exercise training will be given to all control group patients and they will be applied for 2 sessions.(The study will begin before the patients in both the experimental and control groups receive chemotherapy, which is their routine treatment).

Interventions

Pranayama breathing exercise PROCEDURE

Pranayama is an important step in yoga, way of life, and is translated as "the science of breathing, breath control, willful breathing". This alternating breathing-out action also balances the sympathetic and parasympathetic nervous systems, giving the person a state of calm, providing relaxation and positively affecting fatigue. Application steps; Right hand Nasika mudra is performed. Nasika mudra is the mudra where the second and third fingers of the right hand are folded into the palm and the other fingers are exposed. Then the right nostril is closed with the first finger of the right hand. Start by breathing through the left nostril. Then the left nostril is closed with the fourth finger and the breath is held. While the left nostril is closed, the right nostril is opened and inhaled. Breathe again through

Applications to the Intervention Group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Over 18 years old,
• Lung Cancer Stage III and IV,
• Being literate,
• Having sufficient communication skills,
• Does not have any ailment that will reduce the ability to comprehend and understand,
• Agreeing to participate in the research,
• Knowing the diagnosis,
• Receiving chemotherapy treatment,
• ECOG performance score ≤ 2,
• Not using opioids or sedating drugs,
• Patients who can use smart phones themselves or their relatives will be included in the study

You may not qualify if:

• Lung Cancer I., II., stage,
• Receiving radiotherapy,
• Having a history of Brain Metastasis,
• Using integrated health practices in the treatment process,
• Those who exercise regularly
• For patients over 65 years of age, patients with a score below 24 on the mini mental test were not included in the study.
• Research Termination Criteria
• Intervention Group
• Developing additional health problems,
• Unwilling to continue the practice of pranayama breathing exercise,
• Those who lost their lives during the research process,
• Those who do not practice pranayama breathing exercise as recommended or cannot do it effectively,
• The study will be terminated with patients who want to withdraw from the study.
• Control Group
• Developing additional health problems,

Sponsors & Collaborators

• Sanko University: lead

Study Sites (1)

Erciyes University

Kayseri, Talas, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Lecturer

Model Details: Patients with primary diagnosis of lung cancer who met the inclusion criteria of the study and volunteered to participate in the study will constitute the sample of the study. 35 per group for the sample of the study. A total of 70 people will be sampled.

Study Record Dates

• First Submitted: August 1, 2023
• First Posted: August 14, 2023
• Study Start: January 6, 2023
• Primary Completion: January 27, 2024
• Study Completion: January 27, 2024
• Last Updated: May 29, 2025

Record last verified: 2025-05

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)